Severe periorbital edema secondary to imatinib mesylate for chronic myelogenous leukemia

Arch Ophthalmol. 2007 Jul;125(7):985-6. doi: 10.1001/archopht.125.7.985.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Benzamides
  • Edema / chemically induced*
  • Fusion Proteins, bcr-abl / metabolism
  • Humans
  • Imatinib Mesylate
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / metabolism
  • Male
  • Orbital Diseases / chemically induced*
  • Piperazines / adverse effects*
  • Protein Kinase Inhibitors / adverse effects*
  • Protein-Tyrosine Kinases / antagonists & inhibitors*
  • Pyrimidines / adverse effects*

Substances

  • Benzamides
  • Piperazines
  • Protein Kinase Inhibitors
  • Pyrimidines
  • Imatinib Mesylate
  • Protein-Tyrosine Kinases
  • Fusion Proteins, bcr-abl